Literature DB >> 3100665

Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.

A Dolei, A Fattorossi, R D'Amelio, F Aiuti, F Dianzani.   

Abstract

The replication of the human T lymphotropic retrovirus HTLV-III in persistently infected cells is relatively insensitive to the direct antiviral action of human interferon-alpha or -gamma (IFN-alpha or -gamma), showing only a two- to threefold reduction of HTLV-III, even though the host cells are very sensitive to IFN, as shown by vesicular stomatitis virus (VSV)-yield reduction assay (4-5 log reduction of VSV). However, IFN anticellular activity is strongly enhanced in the presence of normal peripheral blood mononuclear cells, suggesting a cell-mediated effect of IFNs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100665     DOI: 10.1089/jir.1986.6.543

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  7 in total

1.  A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).

Authors:  H C Lane; R T Davey; S A Sherwin; H Masur; A H Rook; J F Manischewitz; G V Quinnan; P D Smith; M E Easter; A S Fauci
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

Review 2.  Biological basis for the clinical use of interferon.

Authors:  F Dianzani
Journal:  Gut       Date:  1993       Impact factor: 23.059

3.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.

Authors:  D N SenGupta; R H Silverman
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

5.  Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.

Authors:  Y Shirazi; P M Pitha
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.

Authors:  Y Su; W Popik; P M Pitha
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.

Authors:  R S Kornbluth; P S Oh; J R Munis; P H Cleveland; D D Richman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.